JoseMariaPachecoMD

PubMed

• Trastuzumab deruxtecan in patients with metastatic non-small-cell lung cancer (DESTINY-Lung01): primary results of the HER2-overexpressing cohorts from a single-arm, p...
  Egbert F Smit, Enriqueta Felip, Dipesh Uprety, Misako Nagasaka, Kazuhiko Nakagawa, Luis Paz-Ares Rodríguez, Jose M Pacheco, Bob T Li, David Planchard, Christina Baik, ...> ;The Lancet. Oncology. 2024 Apr 1
• 6 citations
  Intracranial Efficacy of Adagrasib in Patients From the KRYSTAL-1 Trial With-Mutated Non-Small-Cell Lung Cancer Who Have Untreated CNS Metastases.
  Marcelo V Negrao, Alexander I Spira, Rebecca S Heist, Pasi A Jänne, Jose M Pacheco, Jared Weiss, Shirish M Gadgeel, Karen Velastegui, Wenjing Yang, Hirak Der-Torossian...> ;Journal of Clinical Oncology. 2023 Oct 1
• 1 citations
  Vidutolimod in Combination With Atezolizumab With and Without Radiation Therapy in Patients With Programmed Cell Death Protein 1 or Programmed Death-Ligand 1 Blockade-...
  Marcelo V Negrao, Vassiliki A Papadimitrakopoulou, Andrew C Price, Alda L Tam, Muhammad Furqan, Sandeep T Laroia, Erminia Massarelli, Jose Pacheco, John V Heymach, Ann...> ;JTO Clinical and Research Reports. 2023 Mar 1
• 4 citations
  CNS Downstaging: An Emerging Treatment Paradigm for Extensive Brain Metastases in Oncogene-Addicted Lung Cancer.
  Jacob Langston, Tejas Patil, D Ross Camidge, Paul A Bunn, Erin L Schenk, Jose M Pacheco, James Jurica, Timothy V Waxweiler, Brian D Kavanagh, Chad G Rusthoven> ;Lung Cancer. 2023 Apr 1
• 201 citations
  Adagrasib in Non-Small-Cell Lung Cancer Harboring aMutation.
  Pasi A Jänne, Gregory J Riely, Shirish M Gadgeel, Rebecca S Heist, Sai-Hong I Ou, Jose M Pacheco, Melissa L Johnson, Joshua K Sabari, Konstantinos Leventakos, Edwin Ya...> ;The New England Journal of Medicine. 2022 Jul 14
• 282 citations
  Trastuzumab Deruxtecan in HER2-Mutant Non-Small-Cell Lung Cancer.
  Saltos, A. N., Bob T. Li, Egbert F. Smit, Yasushi Goto, Kazuhiko Nakagawa, Hibiki Udagawa, Julien Mazieres, Misako Nagasaka, Lyudmila Bazhenova, Andreas Saltos, Enriqu...> ;The New England Journal of Medicine. 2021 Sep 18
• Rapid Response to Lorlatinib in a Patient With TFG-ROS1 Fusion Positive Inflammatory Myofibroblastic Tumor of the Chest Wall Metastatic to the Brain and Refractory to ...
  Benjamin Carcamo, Ranjan Bista, Harry Wilson, Prasanth Reddy, Jose Pacheco> ;Journal of Pediatric Hematology/oncology. 2021 Jul 1
• 5 citations
  Mobocertinib: A Potential Treatment for NSCLC with EGFR Exon 20 Insertions
  Jose M. Pacheco> ;Cancer Discovery. 2021 Jul 1
• 12 citations
  Immune-related adverse event profile of combination treatment of PD-(L)1 checkpoint inhibitors and bevacizumab in non-small cell lung cancer patients: data from the FD...
  Shuai Bai, Tiantian Tian, Jose M. Pacheco, Motoko Tachihara, Pingping Hu, Jiandong Zhang> ;Translational Lung Cancer Research. 2021 Jun 1
• 1 citations
  CD73 and Adenosine Receptor Signaling as a Potential Therapeutic Target in EGFR-Mutated NSCLC.
  Jose M. Pacheco, Erin L. Schenk> ;Journal of Thoracic Oncology. 2021 Apr 1
• Optimal Therapy for Advanced Non-Small Cell Lung Cancer Without Driver Alterations
  Jose M. Pacheco, Erin L. Schenk, Paul A. Bunn> ;JNCI Cancer Spectrum. 2021 Feb 4
• 11 citations
  Mutational Profile Evaluates Response and Survival to First-Line Chemotherapy in Lung Cancer.
  Park, H. S., Yayi He, Lele Song, Hao Wang, Peixin Chen, Yu Liu, Hui Sun, Xiaobin Li, Shiying Dang, Guifeng Liu, Xinyi Liu, Shifu Chen, Xiaoni Zhang, Paul Hofman, Junji...> ;Advanced Science. 2021 Feb 1
• 16 citations
  Whole exome sequencing (WES) analysis of transformed small cell lung cancer (SCLC) from lung adenocarcinoma (LUAD)
  Tongji Xie, Yan Li, Jianming Ying, Weijing Cai, Junling Li, Kye Young Lee, Biagio Ricciuti, Jose M. Pacheco, Puyuan Xing> ;Translational Lung Cancer Research. 2020 Dec 1
• 13 citations
  2020 Innovation-Based Optimism for Lung Cancer Outcomes.
  Erin L. Schenk, Tejas Patil, Jose M. Pacheco, Paul A. Bunn> ;The Oncologist. 2021 Mar 1
• 99 citations
  The International Association for the Study of Lung Cancer Global Survey on Molecular Testing in Lung Cancer.
  Matthew P. Smeltzer, Murry W. Wynes, Sylvie Lantuejoul, Ross A. Soo, Suresh S. Ramalingam, Marileila Varella-Garcia, M. Taylor, Kristin Richeimer, Kelsey Wood, Kristen...> ;Journal of Thoracic Oncology. 2020 Sep 1
• 2 citations
  Systemic therapy options following first-line chemoimmunotherapy in small-cell lung cancer
  Jose M. Pacheco> ;Journal of Thoracic Disease. 2020 Jun 5
• 21 citations
  Clinicopathologic Characteristics, Treatment Outcomes, and Acquired Resistance Patterns of Atypical EGFR Mutations and HER2 Alterations in Stage IV Non-Small-Cell Lung...
  Tejas Patil, Rao Mushtaq, Sydney Marsh, Christine Azelby, Miheer Pujara, Kurtis D. Davies, Dara L. Aisner, William T. Purcell, Erin L. Schenk, Jose M. Pacheco, Paul A....> ;Clinical Lung Cancer. 2020 May 1
• 1 citations
  Cecal Volvulus as a Rare Complication of Osimertinib Dosed at 160 mg in Patients With EGFR-Mutant Non-small Cell Lung Cancer.
  Tejas Patil, Jose M. Pacheco, Anastasios Dimou, William T. Purcell, Candice Rossi, Paul A. Bunn, Robert C. Doebele, D. Ross Camidge, Lisa Ferrigno> ;Frontiers in Oncology. 2020 Apr 15
• 12 citations
  Immunotherapy for extensive stage small cell lung cancer
  Jose M. Pacheco> ;Journal of Thoracic Disease. 2020 Feb 3
• 5 citations
  KEYNOTE-407: changing the way we treat stage IV squamous non-small cell lung cancer
  Jose M. Pacheco> ;Translational Lung Cancer Research. 2020 Feb 1
• 60 citations
  Co-occurring Alterations in the RAS–MAPK Pathway Limit Response to MET Inhibitor Treatment in MET Exon 14 Skipping Mutation-Positive Lung Cancer
  Julia K Rotow, Philippe Gui, Wei Wu, Victoria M. Raymond, Richard B. Lanman, Frederic J. Kaye, Nir Peled, Ferran Fece de la Cruz, Brandon Nadres, Ryan B. Corcoran, Iwe...> ;Clinical Cancer Research. 2020 Jan 15
• Small cell lung cancer: updates and future directions
  Jose M. Pacheco> ;Journal of Thoracic Disease. 2020 Jan 3
• 1 citations
  Approach to stage IV non-small-cell lung cancer: how to select among first-line therapy options?
  Jose M. Pacheco> ;Current Opinion in Pulmonary Medicine. 2019 Dec 30
• 7 citations
  Temozolomide plus PARP Inhibition in Small-Cell Lung Cancer: Could Patient-Derived Xenografts Accelerate Discovery of Biomarker Candidates?
  Jose M. Pacheco, Lauren Averett Byers> ;Cancer Discovery. 2019 Oct 1
• 16 citations
  Targeted therapies for ROS1-rearranged non-small cell lung cancer.
  Tejas Patil, E. Simons, Rao Mushtaq, Jose M. Pacheco, Robert C. Doebele, Daniel W. Bowles> ;Drugs of Today. 2019 Oct 1
• Join now to see all